Phase I Trial of Autologous Hematopoietic Stem Cell Transplantation with Escalating Doses of Topotecan Combined with Cyclophosphamide and Carboplatin in Patients with Relapsed or Persistent Ovarian or Primary Peritoneal Carcinoma

We designed a phase I clinical trial of escalating doses of topotecan with cyclophosphamide and carboplatin in combination with autologous hematopoietic stem cell transplantation (AHSCT) for the treatment of relapsed or persistent platinum sensitive ovarian or primary peritoneal carcinoma. After ste...

Descripción completa

Detalles Bibliográficos
Autores principales: Litzow, MR, Peethambaram, PP, Safgren, SL, Keeney, GL, Ansell, SM, Dispenzieri, A, Elliott, MA, Gastineau, DA, Gertz, MA, Inwards, DJ, Lacy, MQ, Micallef, INM, Porrata, LF, Lingle, WL, Hartmann, LC, Frost, MH, Barrette, BA, Long, HJ, Suman, VJ, Reid, JM, Ames, MM, Kaufmann, SH
Formato: Texto
Lenguaje:English
Publicado: 2009
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2836387/
https://www.ncbi.nlm.nih.gov/pubmed/19648970
http://dx.doi.org/10.1038/bmt.2009.181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2836387/
https://www.ncbi.nlm.nih.gov/pubmed/19648970
http://dx.doi.org/10.1038/bmt.2009.181

Ejemplares similares